Zandra Life Sciences, the Mumbai-based Indian performance wellness company behind the Reincarn brand, has closed a $5.0M Series A funding round. The capital will fuel the development and market entry of Reincarn Night Reboot, positioned as India's first Sleep Performance Supplement.
Reincarn Night Reboot distinguishes itself with a formulation of 7 clinical-dose ingredients, totaling 4,602mg per sachet, and notably contains zero melatonin, emphasizing full label transparency. Its lead ingredient, Maizinol UP165, is supported by two independent clinical trials, neither of which were funded by Reincarn, adding a layer of scientific validation to the product.
.png&w=3840&q=75)
